Neutralizing Antibodies Against the Porcine Endogenous Retroviruses (PERVs)
Open Access
Abstract
Xenotransplantation using pig cells, tissues or organs may be associated with the transmission of porcine zoonotic or xenozoonotic microorganisms. Porcine endogenous retroviruses (PERVs) pose a special risk for xenotransplantation as these viruses can infect human cells and are integrated in multiple copies in the genome of all pigs and, therefore, they cannot be eliminated as other viruses can. To prevent PERV transmission to the recipient, several strategies have been developed: PERV-C-free animals, siRNA and genomic editing. Another strategy is the generation of vaccines based on neutralizing antibodies in order to protect the recipient. To investigate whether a protective vaccine is feasible in the case of PERV, the recombinant transmembrane (p15E) and the surface envelope (gp70) protein of PERV were cloned, produced, purified and used to immunize rats. For the first time, an adjuvant type that is approved for human use was used. In all cases we obtained virus binding antibodies as shown in Western blot assays and neutralizing antibodies as shown in neutralization assays, indicating the potential for a protective vaccine. The epitopes recognized by the antisera against p15E were determined using overlapping peptides. Two main epitopes were found in the sequence of p15E, one in the membrane proximal external region (MPER) and one in the fusion peptide proximal region (FPPR). The epitopes correspond to epitopes determined previously when immunizing different animal species with p15E of PERV. Antibodies against these epitopes block the conformational changes in the transmembrane envelope proteins that are required for membrane fusion, thereby inhibiting infection. The epitope in the MPER is related by sequence and location to an epitope in the transmembrane envelope protein of the human immunodeficiency virus-1 (HIV-1) recognized by a broadly neutralizing antibody from infected patients.Keywords
All Related Versions
Funding Information
- Wacker Chemie AG, Munich, Germany
- Free University Berlin
- China Scholarship Council (202206857010)
This publication has 41 references indexed in Scilit:
- Transplantation of a genetically modified porcine heart into a live humanNature Medicine, 2025
- Milestones on the path to clinical pig organ xenotransplantationAmerican Journal of Transplantation, 2023
- Novel neutralising antibodies targeting the N-terminal helical region of the transmembrane envelope protein p15E of the porcine endogenous retrovirus (PERV)Immunologic Research, 2013
- Generation of neutralising antibodies against porcine endogenous retroviruses (PERVs)Virology, 2011
- Immunization with the transmembrane protein of a retrovirus, feline leukemia virus: Absence of antigenemia following challengeAntiviral Research, 2010
- A neutralization assay for HIV-2 based on measurement of provirus integration by duplex real-time PCRJournal of Virological Methods, 2009
- Genetic alterations of the long terminal repeat of an ecotropic porcine endogenous retrovirus during passage in human cellsVirology, 2003
- Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?Virology, 2003
- Antigenicity and immunogenicity of the HIV-1 gp41 epitope ELDKWA inserted into permissive sites of the MalE proteinVaccine, 2000
- Genetically-engineered subunit vaccine against feline leukaemia virus: protective immune response in catsVaccine, 1991